Gadolinium-based contrast agent exposures and physical and cognitive disability in multiple sclerosis. Nakamura K, McGinley MP, Jones SE, Lowe MJ, et al. J Neuroimaging 2023;33:85-93.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nakamura K, McGinley MP, Jones SE, Lowe MJ, et al. Gadolinium-based contrast agent exposures and physical and cognitive disability in multiple sclerosis. J Neuroimaging 2023;33:85-93.
PMID: 36181666